Puma Biotechnology, Inc. (PBYI) vs YD Bio Limited (YDES)

Puma Biotechnology, Inc. PBYI 8.27 −15.35%
YD Bio Limited YDES 6.01 −16.30%

Puma Biotechnology, Inc. and YD Bio Limited are both Biotechnology companies. Puma Biotechnology, Inc. and YD Bio Limited are of similar size ($508.7M and $504.3M).

Metric	PBYI	YDES	Biotechnology median
P/E	15.31	—	10.60
P/S	1.82	—	9.40
P/B	3.04	—	2.13
Price to free cash flow	14.74	—	25.18
EV/EBITDA	8.54	—	0.66
EV/Sales	1.51	—	9.02
Earnings yield	6.53%	—	(32.88%)
Free cash flow yield	6.78%	—	(23.13%)

Metric	PBYI	YDES	Biotechnology median
Gross margin	74.83%	—	68.51%
Operating margin	13.16%	—	0.00%
Net margin	11.55%	—	0.00%
Free cash flow margin	17.79%	—	0.00%
Return on equity	21.97%	—	(51.96%)
Return on assets	13.78%	—	(46.06%)
Return on invested capital	42.61%	—	0.00%

Metric	PBYI	YDES	Biotechnology median
Revenue growth (TTM)	(2.86%)	—	6.76%
EPS growth (last fiscal year)	(1.61%)	—	29.88%
Revenue growth, 5-year CAGR	0.29%	—	9.75%
Net income growth, 5-year CAGR	0.00%	—	0.00%

Metric	PBYI	YDES	Biotechnology median
Debt to equity	0.00	—	0.00
Current ratio	2.91	—	4.97
Net debt to EBITDA	(1.60)	—	1.01

Metric	PBYI	YDES	Biotechnology median
Dividend yield	—	—	0.41%
Payout ratio	—	—	—

Metric	PBYI	YDES	Biotechnology median
Market cap	504.33m	508.65m	161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack